Vedi Herbals Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.20 M
as on 11-12-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Revenue -99.85%
(FY 2022)
- Profit 95.40%
(FY 2022)
- Ebitda -104.18%
(FY 2022)
- Net Worth -0.42%
(FY 2022)
- Total Assets -23.82%
(FY 2022)
About Vedi Herbals
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Sourab Agarwal and Priyanka Agarwal serve as directors at the Company.
- CIN/LLPIN
U36990OR2017PTC026735
- Company No.
026735
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Khorda, Odisha, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vedi Herbals Private Limited offer?
Vedi Herbals Private Limited offers a wide range of products and services, including Ayurveda Products, Natural Hair & Skin Care, Herbs, Ashwagandha (Immunity & Stress), Health Conditions, Cold & Cough, Popular Category, Sexual Wellness, Skin Care, Bath Essentials.
Who are the key members and board of directors at Vedi Herbals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sourab Agarwal  | Director | 17-Mar-2017 | Current |
| Priyanka Agarwal | Director | 17-Mar-2017 | Current |
Financial Performance of Vedi Herbals.
Vedi Herbals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.85% decrease. The company also saw a substantial improvement in profitability, with a 95.4% increase in profit. The company's net worth dipped by a decrease of 0.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vedi Herbals?
In 2022, Vedi Herbals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Balbhadra Developers Private LimitedActive 8 years 7 months
Sourab Agarwal and Priyanka Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vedi Herbals?
Vedi Herbals has a workforce of 9 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vedi Herbals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vedi Herbals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
